Evaluation in nonhuman primates: evaluation of the physical dependence capacities of oripavine-thebaine partial agonists in patas monkeys.
D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D003496:Cyclazocine / Q000494:pharmacology; D005260:Female; D000882:Haplorhini; D006801:Humans; D008297:Male; D051379:Mice; D009019:Morphinans / Q000494:pharmacology; D009020:Morphine / Q000037:antagonists & inhibitors; D009021:Morphine Dependence; D009269:Nalorphine / Q000494:pharmacology; D009270:Naloxone / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology*; D010423:Pentazocine / Q000494:pharmacology; D013239:Stereotyped Behavior / Q000187:drug effects; D013375:Substance Withdrawal Syndrome / Q000139:chemically induced*; D019966:Substance-Related Disorders; D013797:Thebaine / Q000494:pharmacology*; D013997:Time Factors
D000700:Analgesics; D009019:Morphinans; D009292:Narcotic Antagonists; D013797:Thebaine; D009270:Naloxone; D009020:Morphine; D003496:Cyclazocine; D010423:Pentazocine; D009269:Nalorphine